logo

For the Inventor, By the Inventor

New York, NY, United States of America

Govindaswami Ragupathi

This inventor holds 18 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Glycoconjugate Chemistry. Top assignees: Sloan-Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Govindaswami Ragupathi. Retrieved from https://idiyas.com/inventor/govindaswami-ragupathi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.1

ph-index = 6

Forward Citations = 119(Granted Patents)


Company Filing History:

goldMedal15 out of 519 
 
Sloan-Kettering Institute for Cancer Research
 patents
silverMedal3 out of 621 
 
Memorial Sloan Kettering Cancer Center
 patents

Years Active: 2003-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Triterpene Saponins
Glycoconjugates
Cancer Vaccines
Glycoamino Acids
Glycopeptide Conjugates
Methods of Synthesis
Polyvalent Conjugates
Intermediates
Glycoepitopes
Variants
Uses
18 patents (USPTO):Explore Patents
1. 12698304 - Triterpene saponin variants, methods of synthesis and use thereof (2026-08-04),
2. 12227535 - Triterpene saponins, methods of synthesis and uses thereof (2025-02-18),
3. 11629162 - Triterpene saponin variants, methods of synthesis and use thereof (2023-04-18),
4. 11447515 - Triterpene saponins, methods of synthesis and uses thereof (2022-09-20),
5. 9718850 - Triterpene saponins, methods of synthesis and uses thereof (2017-08-01),
6. 9572875 - Polyvalent conjugate vaccine for cancer (2017-02-21),
7. 9464116 - Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof (2016-10-11),
8. 9149516 - Polyvalent conjugate vaccine for cancer (2015-10-06),
9. 8623378 - Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof (2014-01-07),
10. 8540964 - Polyvalent conjugate vaccine for cancer (2013-09-24),
11. 8092780 - Polyvalent conjugate vaccine for cancer (2012-01-10),
12. 7879335 - Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof (2011-02-01),
13. 7854934 - Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof (2010-12-21),
14. 7550146 - Glycopeptide conjugates and uses thereof (2009-06-23),
15. 7479266 - Polyvalent conjugate vaccine for cancer (2009-01-20),

Title: The Innovative Mind of Govindaswami Ragupathi

Introduction:

Govindaswami Ragupathi, a pioneering inventor based in New York, NY, is known for his groundbreaking contributions to the field of technology and innovation. His relentless pursuit of excellence has led to numerous patents and advancements in various industries.

Latest Patents:

Govindaswami Ragupathi's latest patents include cutting-edge technologies in artificial intelligence, renewable energy, and healthcare. His innovative solutions have garnered attention worldwide for their potential to revolutionize the way we live and work.

Career Highlights:

With a career spanning over two decades, Govindaswami Ragupathi has held key roles in leading tech companies, where he has spearheaded research and development projects that have resulted in game-changing inventions. His ability to think outside the box and push the boundaries of what is possible has set him apart as a true visionary in the field of innovation.

Collaborations:

Govindaswami Ragupathi has collaborated with top researchers, engineers, and scientists from around the globe to bring his ideas to life. His partnerships with industry leaders have paved the way for successful product launches and have solidified his reputation as a sought-after expert in the world of patents and inventions.

Conclusion:

In conclusion, Govindaswami Ragupathi's passion for innovation and his dedication to creating a better future through technology make him a standout figure in the world of inventors. His relentless pursuit of excellence and his

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…